Charles Institute - Research
The research at the Charles Institute will address common skin diseases
such as psoriasis, eczema, skin cancer and rare genetic skin diseases.
At the launch of the Institute are Ms. Mary Harney T.D., Minister for Health & Children; Prof Desmond Fitzgerald, UCD Vice-President for Research; & Mr Peter O’Flanagan, Chair of the Board of the City of Dublin Skin & Cancer Hospital
The application of frontier biotechnologies will provide exciting
opportunities to develop worthwhile new therapies for the ultimate
benefit of the patient. These will include:
- Micro-therapeutics – generation of new drugs for clinical research.
- Stem cell therapy – regenerative medicine, tissue repair and wound healing
- Tissue engineering – creation of artificial skin
- Nanobiology – the development of nanomaterials for drug and gene delivery.
The research objectives of the Charles Institute are to:
- Understand the fundamental nature of skin disease
- Build translational research programmes that will transform dermatology
- Leverage existing areas of academic, research and clinical excellence at UCD
- Meet national and international training needs in dermatology
- Integrate research and training in dermatology
